A once-daily oral nonpeptide GLP-1 conferred significant improvements in body weight, HbA1c and other cardiometabolic ...

The global HbA1c testing market size was valued at USD 2.41 billion in 2024 and is projected to hit around USD 3.85 billion by 2033, growing at a CAGR of 5.5% during the forecast ...

The HbA1c testing market presents opportunities driven by rising Type 2 diabetes cases and advancements in testing ...

The company doesn't seem like it will generate pops in key fundamentals anytime soon.

The outlook for full year 2025 remains unchanged at flat to 1% currency-neutral revenue growth, consistent with the Q2 update. Margins guidance is also unchanged. Q3 reported a slight revenue and ...

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, and Gencurix, Inc., a leading Korean developer of oncology testing solutions, today announced ...

Rezon Bio today announced its launch as a European contract development and manufacturing organization (CDMO) for biologics. It enters the market as a new brand, but builds on a proven legacy of ...

Tirzepatide was superior to placebo in lowering HbA1c and reducing BMI in children and adolescents with type 2 diabetes. Topline results were announced from a phase 3 trial evaluating tirzepatide in ...

Marc Santos is a Guides Staff Writer from the Philippines. He's a seasoned writer with over four years of industry experience, and he is an enjoyer of all things difficult in gaming. If Marc's not ...

Borderlands 4’s Bio-Bulkhead is one of the first bosses you fight in the game and the grappling hook is fundamental to get to the boss. Unlike anything you have faced so far in the game, Bio-Bulkhead ...

HERCULES, Calif. — Bio-Rad Laboratories, a global provider of life science research and clinical diagnostics products, launched EZ-Check Salmonella spp. Kit, describing it as a rapid qualitative test ...